维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Heching N"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Prognostic role of serum cytokeratin 19 fragments in advanced non-small cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival 显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
2	Evaluation of tissue polypeptide specific antigen,CYFRA21-1 and carcinoembryonic antigen in nonsmall cell lung carcinoma;does the combined use of cytokeratin markers give any additional information显示文摘	Nisman B Lafair J Heching N	2008	Gancer2008，1582，：	1
3	Prognostic role of serum cytokeratin 19 fragment in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	British Journal of Cancer2008，98，1：	1
4	Prognostic role of serum cytokeratin 19 fragment in advanced non-small- cell lung cancer:association of nmrker changes after two chemotherapy cycles with different measures of clinical response and survival 显示文摘	Nisman B Biran H Heching N	2008	Brit J Can2008，98，1：	1
5	Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
6	Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N		0，，：	1
7	Prognostic role of serum cy- tokeratin 19 fragments in advanced non-small-cell lung cancer: associ- ation of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
8	Competition in a global change environment: the importance of different plant traits for competitive success显示文摘	Teuge ls H N ijs I Van Heche P	1995	Journal of Biogeo- graphy1995，22，：	1
9	Prognostic role of ser-um cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemo-therapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N		0，，01：	1
10	Prognostic role of serum cy-tokeratin 19 fragments in advanced non-small-cell lung cancer:as-sociation of marker changes after two chemotherapy cycles with dif-ferent measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
11	The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer显示文摘	Nisman B Heching N Biran H	2006	Tumour Biol2006，27，1：	1
12	Prognostic role of serum cytoeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival 显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
13	Prognostic role of serum cytokeratin 19 fragments in advanced non - small - cell lung canc- er: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
14	Evaluation of tissue poly- peptide specific antigen, CYFRA 21 - 1, and carcinoembryonic antigen in nonsmall cell lung carcinoma:does the combined use of cytokeratin markers give any additional information? 显示文摘	Nisman B Lafair J Heching N	1998	Cancer1998，82，10：	1
15	Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N		0，，01：	1
16	Evaluation Tissue polypeptide specific antigen, CYFRA21-1 and carcincembryonic antigen in nonsmall cell lung carcinoma: Does the combined used of cytokeratin markers give any additional information? 显示文摘	Nisman B Lrafair J Heching N	1998	Cancer1998，82，：	1
17	Prognostic role of serum cytokeratin 19 fragments in advanced non- small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of chinical response and survival 显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
18	Evaluation of tissue poly- peptide specific antigen,CYFRA 21 1 ,and earcinoembryonie anti-gen in nonsmall cell lung carcinoma:does the combined use of cy tokeratin markers give any additional information? 显示文摘	Nisman B Lafair J Heching N	1998	Cancer1998，82，10：	1
19	Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma显示文摘	Nisman B Lafair J Heching N	1998	Cancer1998，82，10：	1
20	Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示